ADRB2 and facioscapulohumeral muscular dystrophy: While further trials in FSHD patients with salbutamol have shown no major impact as a routine treatment for FSHD [18, 137–139], investigations on β2-AR have revealed an involvement in the regulation of the D4Z4 array in somatic cells [140].